AJR Am J Roentgenol

1. KIM TK
   Editorial Comment: Differentiating Hepatic Adenomas From Focal Nodular Hyperplasias With Gadoxetic Acid-Enhanced MRI-More Complicated Than Thought.
   AJR Am J Roentgenol. 2022 Aug 17. doi: 10.2214/AJR.22.28384.
   

   >> Share

   
   
2. ISEKE S, Zeevi T, Kucukkaya AS, Raju R, et al
   Machine-Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.
   AJR Am J Roentgenol. 2022 Aug 17. doi: 10.2214/AJR.22.28077.
   

   >> Share

   
   

   
   Am J Gastroenterol

3. WENTWORTH BJ, Henry ZH, Siragy HM
   How I Approach It: Adrenal Insufficiency in Cirrhosis.
   Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00445.
   

   >> Share

   
   
4. CALVARUSO V, Celsam C, D'Ambrosio R, Simone F, et al
   RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
   Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00413.
   

   >> Share

   
   
5. MOON AM, Ioannou GN
   Moving Away from a One-Size-Fits-All Approach to Hepatocellular Carcinoma Surveillance.
   Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00430.
   

   >> Share

   
   
6. INNES H, Hamill V, McDonald SA, Hayes PC, et al
   Comparing predicted probability of hepatocellular carcinoma in cirrhosis patients to the general population: an opportunity to improve risk communication?
   Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00428.
   

   >> Share

   
   
7. DAJTI E, Ravaioli F, Marasco G, Alemanni LV, et al
   A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease.
   Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00415.
   

   >> Share

   
   
8. BHAVSAR-BURKE I, Guardiola JJ, Hamade N, Gerke S, et al
   Use of a cirrhosis admission order set improves adherence to quality metrics and may decrease hospital length of stay.
   Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00463.
   

   >> Share

   
   
9. KUTMUTIA R, Tittanegro T, China L, Forrest E, et al
   Evaluating the role of antibiotics in patients admitted to hospital with decompensated cirrhosis: lessons from the ATTIRE trial.
   Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00458.
   

   >> Share

   
   

   
   Am J Pathol

10. DONG MP, Thanh Thuy LT, Hoang DV, Hai H, et al
    Soluble Immune Checkpoint Protein CD27 Is a Novel Prognostic Biomarker of Hepatocellular Carcinoma Development in Hepatitis C Virus-Sustained Virological Response Patients.
    Am J Pathol. 2022 Aug 11. pii: S0002-9440(22)00207.
    

    >> Share

    
    

    
    BMC Cancer

11. ZHANG G, Lv X, Yang Q, Liu H, et al
    Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma.
    BMC Cancer. 2022;22:888.
    

    >> Share

    
    
12. AMBROZKIEWICZ F, Trailin A, Cervenkova L, Vaclavikova R, et al
    CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence.
    BMC Cancer. 2022;22:884.
    

    >> Share

    
    

    
    Br J Surg

13. HUO TI, Ho SY, Liao JI
    Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.
    Br J Surg. 2022 Aug 18. pii: 6670908. doi: 10.1093.
    

    >> Share

    
    
14. HOBEIKA C, Cauchy F
    Author response to: Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.
    Br J Surg. 2022 Aug 18. pii: 6670912. doi: 10.1093.
    

    >> Share

    
    
15. SIRIWARDENA AK
    Author response to: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6586615. doi: 10.1093.
    

    >> Share

    
    
16. YAQUB S
    Comment on: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6587119. doi: 10.1093.
    

    >> Share

    
    
17. OLTHOF PB, Buettner S, Andreatos N, Wang J, et al
    KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:804-807.
    

    >> Share

    
    

    
    Cancer Res

18. BARTON MC, Lozano G
    p53 Activation Paradoxically Causes Liver Cancer.
    Cancer Res. 2022;82:2824-2825.
    

    >> Share

    
    

    
    Dig Dis Sci

19. PREMKUMAR M, Mehtani R, Kulkarni AV, Duseja AK, et al
    Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding.
    Dig Dis Sci. 2022 Aug 19. pii: 10.1007/s10620-022-07656.
    

    >> Share

    
    

    
    Eur Radiol

20. CHERNYAK V, Tang A, Do RKG, Kamaya A, et al
    Liver imaging: it is time to adopt standardized terminology.
    Eur Radiol. 2022;32:6291-6301.
    

    >> Share

    
    
21. JOO I, Morrow KW, Raman SS, McWilliams JP, et al
    CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
    Eur Radiol. 2022;32:6327-6335.
    

    >> Share

    
    
22. VIETTI VIOLI N, Gnerre J, Law A, Hectors S, et al
    Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology.
    Eur Radiol. 2022;32:6493-6503.
    

    >> Share

    
    
23. WANG H, Guo Y, Yan B, Zhang Q, et al
    Development and validation of a prediction model based on clinical and CT features for invasiveness of K. pneumoniae liver abscess.
    Eur Radiol. 2022;32:6397-6406.
    

    >> Share

    
    
24. SALEH GA, Elmokadem AH, Razek AA, El-Morsy A, et al
    Utility of diffusion tensor imaging in differentiating benign from malignant hepatic focal lesions.
    Eur Radiol. 2022 Aug 18. pii: 10.1007/s00330-022-09091.
    

    >> Share

    
    
25. CHEN G, Jiao D, Peng S, Chen X, et al
    Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
    Eur Radiol. 2022 Aug 18. pii: 10.1007/s00330-022-09074.
    

    >> Share

    
    
26. ZHOU C, Lu X, Wang Y, Qian X, et al
    Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma.
    Eur Radiol. 2022 Aug 17. pii: 10.1007/s00330-022-09065.
    

    >> Share

    
    

    
    Gastroenterology

27. CLIFFORD C, Ryan R, Houlihan D
    An interesting case of hepatomegaly.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00945.
    

    >> Share

    
    
28. DEBOSCH B
    Targeting de novo lipogenesis by different approaches shows promise in non-alcoholic steatohepatitis.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00915.
    

    >> Share

    
    
29. D'ALESSIO A, Pinato DJ
    Dissecting the tumour microenvironment to predict immunotherapy response in hepatocellular cancer.
    Gastroenterology. 2022 Aug 11. pii: S0016-5085(22)00950.
    

    >> Share

    
    

    
    Gut

30. BYRNE CD, Targher G
    Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed.
    Gut. 2022;71:1695-1696.
    

    >> Share

    
    
31. SIMON TG, Roelstraete B, Hagstrom H, Sundstrom J, et al
    Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
    Gut. 2022;71:1867-1875.
    

    >> Share

    
    

    
    Hepatology

32. SERPER M, Kaplan DE, Taddei TH, Tapper EB, et al
    Non-selective Beta Blockers, Hepatic Decompensation and Mortality in Cirrhosis: A National Cohort Study.
    Hepatology. 2022 Aug 19. doi: 10.1002/hep.32737.
    

    >> Share

    
    
33. DEMORY A, Peron JM, Calderaro J, Selves J, et al
    Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation.
    Hepatology. 2022 Aug 18. doi: 10.1002/hep.32734.
    

    >> Share

    
    
34. LOUREIRO D, Tout I, Narguet S, Bed CM, et al
    Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C or nonalcoholic steatohepatitis.
    Hepatology. 2022 Aug 16. doi: 10.1002/hep.32731.
    

    >> Share

    
    

    
    Indian J Gastroenterol

35. YASMIN A, Rukunuzzaman M, Karim ASMB, Alam R, et al
    Ratio of aspartate aminotransferase to alanine aminotransferase and alkaline phosphatase to total bilirubin in Wilsonian acute liver failure in children.
    Indian J Gastroenterol. 2022;41:224-230.
    

    >> Share

    
    

    
    J Clin Oncol

36. RAPHAEL MJ, Karanicolas PJ
    Regional Therapy for Colorectal Cancer Liver Metastases: Which Modality and When?
    J Clin Oncol. 2022 Jun 1:JCO2102505. doi: 10.1200/JCO.21.02505.
    

    >> Share

    
    

    
    J Hepatol

37. GEHRING AJ, MacParland SA
    Intrahepatic T cells with NK-like properties: expanding the repertoire of lymphocytes sensitive to bystander activation.
    J Hepatol. 2022 Aug 12. pii: S0168-8278(22)02985.
    

    >> Share

    
    
38. DEGASPERI E, Anolli MP, Uceda Renteria SC, Sambarino D, et al
    Bulevirtide monotherapy for 48 Weeks in hdv patients with compensated cirrhosis and clinically significant portal hypertension.
    J Hepatol. 2022 Aug 13. pii: S0168-8278(22)02980.
    

    >> Share

    
    
39. AGGARWAL A, Montanari NR, Ramirez R, Diehl L, et al
    Reply to: Hepatocyte expression of hepatitis B surface and core antigens across phases of chronic hepatitis B infection.
    J Hepatol. 2022 Aug 14. pii: S0168-8278(22)03000.
    

    >> Share

    
    
40. BAILEY AL, Diamond MS
    Hepatopathology of flaviviruses.
    J Hepatol. 2022 Aug 15. pii: S0168-8278(22)00339.
    

    >> Share

    
    
41. JI D, Chen Y, Bi J, Shang Q, et al
    Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B.
    J Hepatol. 2022 Aug 16. pii: S0168-8278(22)02982.
    

    >> Share

    
    

    
    J Pediatr Surg

42. JIANG L, Wang N, Cheng S, Liu Y, et al
    RNA-sequencing identifies novel transcriptomic signatures in intestinal failure-associated liver disease.
    J Pediatr Surg. 2022;57:158-165.
    

    >> Share

    
    
43. YILMAZ S, Kutluturk K, Koc C, Akbulut S, et al
    Letter to editor in response to: Management and outcome of hepatic artery thrombosis with whole-liver transplantation using donors less than one year of age.
    J Pediatr Surg. 2022 Aug 5. pii: S0022-3468(22)00504.
    

    >> Share

    
    

    
    Oncogene

44. GAO M, Qi Z, Deng M, Huang H, et al
    The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1.
    Oncogene. 2022;41:4018-4027.
    

    >> Share

    
    

    
    PLoS Genet

45. KIYOSE H, Nakagawa H, Ono A, Aikata H, et al
    Comprehensive analysis of full-length transcripts reveals novel splicing abnormalities and oncogenic transcripts in liver cancer.
    PLoS Genet. 2022;18:e1010342.
    

    >> Share

    
    

    
    PLoS One

46. THI THU PN, Quynh MNT, Van HN, Thanh HN, et al
    A logistic regression model based on inpatient health records to predict drug-induced liver injury caused by ramipril-An angiotensin-converting enzyme inhibitor.
    PLoS One. 2022;17:e0272786.
    

    >> Share

    
    
47. GURNEY J, Whitehead J, Kerrison C, Stanley J, et al
    Equity of travel required to access first definitive surgery for liver or stomach cancer in New Zealand.
    PLoS One. 2022;17:e0269593.
    

    >> Share

    
    
48. NIEHUES MB, Tomaz LA, Ferreira MS, Baldassini WA, et al
    Assessment of corn wet distillers grains fed to crossbred bulls on feeding behavior, rumen morphology, liver abscesses and blood parameters.
    PLoS One. 2022;17:e0271461.
    

    >> Share

    
    
49. CHENG J, Wang Z, Liu J, Dou C, et al
    Value of 3D printing technology combined with indocyanine green fluorescent navigation in complex laparoscopic hepatectomy.
    PLoS One. 2022;17:e0272815.
    

    >> Share

    
    

    
    Radiology

50. KWAG M, Choi SH, Choi SJ, Byun JH, et al
    Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI.
    Radiology. 2022 Aug 16:220659. doi: 10.1148/radiol.220659.
    

    >> Share

    
    

    
    Transplant Proc

51. RASZEJA-WYSZOMIRSKA J, Niewinski G, Graczynska A, Morawiec S, et al
    Clinical Implication of Plasma CD163 in Patients With Acute-on-Chronic Liver Failure.
    Transplant Proc. 2022;54:1011-1016.
    

    >> Share

    
    
52. FIGIEL W, Smoter P, Krasnodebski M, Rykowski P, et al
    The Utility of Early Allograft Dysfunction Components in Determining 90-Day Liver Graft Survival.
    Transplant Proc. 2022;54:1017-1020.
    

    >> Share

    
    
53. KOSCIELSKA M, Matuszkiewicz-Rowinska J, Giercuszkiewicz D, Krawczyk M, et al
    Simultaneous Liver-Kidney Transplantation and the Use of Intraoperative Dialysis: A Monocenter Study.
    Transplant Proc. 2022 Apr 11. pii: S0041-1345(22)00183.
    

    >> Share

    
    
54. ROVGALIYEV B, Tan MY, Lee KW, Oh SC, et al
    Sirolimus Attenuates Calcineurin Inhibitor-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
    Transplant Proc. 2022 Aug 14. pii: S0041-1345(22)00449.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share